Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution.

European journal of cancer (Oxford, England : 1990) - 26 Jul 2026

Corre Romain, Monnet Isabelle, Moreau Lionel, Pinsolle Julian, Hominal Stéphane, Campana Marion, Chikouche Reda, Slaouti Philippe, Tavernier Jean-Yves, Clarot Caroline, Kuntz Pierre, Fouet Kevin, Rabut Hong, Dehette Stephanie, Thirard Laurence, Paysse Magalie, Nunes David, Letierce Alexia, Morel Hugues, Debieuvre Didier

Abstract excerpt

BACKGROUND: The proportion of patients aged ≥ 80 years with non-small-cell lung cancer (NSCLC) is rising, yet data on their management remain scarce. This study analysed changes in treatment and survival in this population over a decade. METHODS: The KBP-2010 and KBP-2020 cohorts are prospective, nationwide cohorts including patients diagnosed with primary lung cancer in France in 2010 and 2020, respectively. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to France

Share to EGFR gene

Share to Lung Neoplasms

Share to Mutation

Share to Treatment Outcome

Source

Identifiers

PMID: 42235466
DOI: 10.1016/j.ejca.2026.116845

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution.PMID 42235466Read ↗

Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.Semantic proximity Read ↗

Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study.Semantic proximity Read ↗

Prospective cohort study of clinical characteristics and management patterns for patients with non-small-cell lung cancer in the Russian Federation: EPICLIN-Lung.Semantic proximity Read ↗

Real-World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)-Mutant Metastatic Non-Small Cell Lung Cancer, From a US-Based Clinico-Genomic Database.Semantic proximity Read ↗

Real-World Survival Outcomes in Non-Small Cell Lung Cancer: The Impact of Genomic Testing and Targeted Therapies in a Latin American Middle-Income Country.Semantic proximity Read ↗

Metastatic non-small-cell lung cancer without driver mutations: projections by therapy line in Western Europe, 2021-2026.Semantic proximity Read ↗

A Single Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally-Advanced Non-small Cell Lung Cancer (NSCLC)Semantic proximity Read ↗

FIN-EGFRprint: a Finnish real-world study on treatments and outcomes in advanced NSCLC with common EGFR mutations.Semantic proximity Read ↗

Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC RegistrySemantic proximity Read ↗

A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.Semantic proximity Read ↗

First-line treatment patterns and real-world outcomes in patients with advanced KRAS-mutated non-small cell lung cancer with high unmet need.Semantic proximity Read ↗

Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.